Viktor Wixler

2.9k total citations
55 papers, 2.0k citations indexed

About

Viktor Wixler is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Viktor Wixler has authored 55 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Immunology and 12 papers in Immunology and Allergy. Recurrent topics in Viktor Wixler's work include interferon and immune responses (14 papers), Cell Adhesion Molecules Research (12 papers) and Influenza Virus Research Studies (10 papers). Viktor Wixler is often cited by papers focused on interferon and immune responses (14 papers), Cell Adhesion Molecules Research (12 papers) and Influenza Virus Research Studies (10 papers). Viktor Wixler collaborates with scholars based in Germany, United States and Netherlands. Viktor Wixler's co-authors include Stephan Ludwig, Ulf R. Rapp, Ludmilla Wixler, U Smola, Christina Ehrhardt, Carolin Nordhoff, Geoffrey M. Cooper, Jorge Moscat, Yvonne Boergeling and Hong Cai and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Viktor Wixler

55 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Viktor Wixler Germany 26 1.2k 612 331 281 264 55 2.0k
Hyeseon Cho United States 21 1.1k 1.0× 413 0.7× 170 0.5× 231 0.8× 281 1.1× 30 1.8k
Stefanie Kliche Germany 27 720 0.6× 966 1.6× 288 0.9× 406 1.4× 213 0.8× 60 2.1k
Teresa A. Doggett United States 21 788 0.7× 503 0.8× 286 0.9× 199 0.7× 178 0.7× 30 1.8k
Patrick Costello United Kingdom 19 846 0.7× 1.5k 2.4× 246 0.7× 341 1.2× 246 0.9× 27 2.5k
Roderick Bronson United States 14 744 0.6× 503 0.8× 371 1.1× 254 0.9× 375 1.4× 19 1.6k
Noriko Toyama‐Sorimachi Japan 30 1.2k 1.0× 1.3k 2.1× 195 0.6× 349 1.2× 660 2.5× 73 3.0k
N Kitamura Japan 24 1.3k 1.1× 415 0.7× 326 1.0× 321 1.1× 253 1.0× 36 2.8k
Hugh H. Reid Australia 31 917 0.8× 2.0k 3.2× 450 1.4× 479 1.7× 216 0.8× 49 3.5k
Tiina Öhman Finland 22 924 0.8× 357 0.6× 267 0.8× 161 0.6× 227 0.9× 36 1.5k
Kyung Ae Ko United States 17 950 0.8× 1.5k 2.5× 180 0.5× 207 0.7× 190 0.7× 32 2.6k

Countries citing papers authored by Viktor Wixler

Since Specialization
Citations

This map shows the geographic impact of Viktor Wixler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Wixler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Wixler more than expected).

Fields of papers citing papers by Viktor Wixler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viktor Wixler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Wixler. The network helps show where Viktor Wixler may publish in the future.

Co-authorship network of co-authors of Viktor Wixler

This figure shows the co-authorship network connecting the top 25 collaborators of Viktor Wixler. A scholar is included among the top collaborators of Viktor Wixler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viktor Wixler. Viktor Wixler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wixler, Viktor, et al.. (2024). The anti-inflammatory and tolerogenic potential of small spleen peptides. Frontiers in Immunology. 15. 1449657–1449657. 1 indexed citations
2.
Wixler, Viktor, et al.. (2024). Conversion of dendritic cells into tolerogenic or inflammatory cells depends on the activation threshold and kinetics of the mTOR signaling pathway. Cell Communication and Signaling. 22(1). 281–281. 3 indexed citations
3.
Wixler, Viktor, et al.. (2023). Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer. Molecular Therapy — Oncolytics. 31. 100741–100741. 1 indexed citations
4.
Brachvogel, Bent, et al.. (2017). The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release. American Journal Of Pathology. 187(11). 2388–2398. 11 indexed citations
5.
Silva, Izabella Thaís, Karen Luise Lang, Sabine Eva Dudek, et al.. (2015). In Vitro and In Vivo Antitumor Activity of a Novel Semisynthetic Derivative of Cucurbitacin B. PLoS ONE. 10(2). e0117794–e0117794. 28 indexed citations
6.
Nordhoff, Carolin, et al.. (2014). β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling. Cell Communication and Signaling. 12(1). 29–29. 57 indexed citations
7.
Wixler, Viktor, Neil Smyth, Adelheid Korb‐Pap, et al.. (2014). FHL2 regulates the resolution of tissue damage in chronic inflammatory arthritis. Annals of the Rheumatic Diseases. 74(12). 2216–2223. 12 indexed citations
8.
Nordhoff, Carolin, Ruth Chiquet‐Ehrismann, Karin Loser, et al.. (2013). The LIM-Only Protein FHL2 Attenuates Lung Inflammation during Bleomycin-Induced Fibrosis. PLoS ONE. 8(11). e81356–e81356. 25 indexed citations
10.
Wixler, Viktor, et al.. (2011). Identification and characterisation of novel Mss4-binding Rab GTPases. Biological Chemistry. 392(3). 239–48. 18 indexed citations
11.
Wixler, Ludmilla, et al.. (2010). Monoclonal Antibodies Against the PB1-F2 Protein of H1N1 Influenza A Virus. Hybridoma. 29(4). 321–326. 5 indexed citations
12.
Park, Jung, et al.. (2008). Umbilical Cord Blood Stem Cells: Induction of Differentiation into Mesenchymal Lineages by Cell–Cell Contacts with Various Mesenchymal Cells. Tissue Engineering Part A. 15(2). 397–406. 13 indexed citations
13.
Samson, Thomas, et al.. (2007). Def-6, a Guanine Nucleotide Exchange Factor for Rac1, Interacts with the Skeletal Muscle Integrin Chain α7A and Influences Myoblast Differentiation. Journal of Biological Chemistry. 282(21). 15730–15742. 29 indexed citations
14.
Samson, Thomas, Neil Smyth, Olaf Wendler, et al.. (2004). The LIM-only Proteins FHL2 and FHL3 Interact with α- and β-Subunits of the Muscle α7β1 Integrin Receptor. Journal of Biological Chemistry. 279(27). 28641–28652. 86 indexed citations
15.
Mourabit, Haquima El, Jan Köster, Holger Sondermann, et al.. (2002). The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin α5 and α6 subunits. Matrix Biology. 21(2). 207–214. 40 indexed citations
16.
Wixler, Viktor, Emmanuel Laplantine, Dirk Geerts, et al.. (1999). Identification of novel interaction partners for the conserved membrane proximal region of α‐integrin cytoplasmic domains. FEBS Letters. 445(2-3). 351–355. 56 indexed citations
17.
Cai, Hong, U Smola, Viktor Wixler, et al.. (1997). Role of Diacylglycerol-Regulated Protein Kinase C Isotypes in Growth Factor Activation of the Raf-1 Protein Kinase. Molecular and Cellular Biology. 17(2). 732–741. 264 indexed citations
18.
Hagemann, Carsten, Andreas Kalmes, Viktor Wixler, et al.. (1997). The regulatory subunit of protein kinase CK2 is a specific A‐Raf activator. FEBS Letters. 403(2). 200–202. 84 indexed citations
19.
Wixler, Viktor, et al.. (1995). Mutant Frequency at the H-2K Class 1 and HPRT Genes in T Lymphocytes from the X-ray-exposed Mouse. International Journal of Radiation Biology. 67(4). 421–430. 9 indexed citations
20.
Wixler, Viktor, et al.. (1994). Isolation and quantification of class 1 MHC gene mutants in mouse T cells by immunoselection with a magnetic cell sorter (MACS). Journal of Immunological Methods. 171(1). 121–130. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026